Skip to main content
SpringerLink
Log in

Sepsis and Septic Shock in Cirrhotic Patients

  • Chapter
  • First Online:
Critical Care for Potential Liver Transplant Candidates

  • 854 Accesses

Abstract

Critically ill patients with liver cirrhosis are at risk of developing severe infections and specifically sepsis and/or septic shock. The subjects of this chapter are the epidemiology of and prognosis and critical care therapy for septic patients with liver failure. Severe hepatic dysfunction in association with sepsis and/or septic shock can result in a high mortality rate and requires intensive care management with specific expertise.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Borzio M, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis. 2001;33(1):41–8.

    Article  CAS  Google Scholar 

  2. Bernard B, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29(6):1655–61.

    Article  CAS  Google Scholar 

  3. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28(1):26–42.

    Article  CAS  Google Scholar 

  4. Wasmuth HE, et al. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol. 2005;42(2):195–201.

    Article  CAS  Google Scholar 

  5. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology. 1986;6(2):252–62.

    Article  CAS  Google Scholar 

  6. Katsounas A, et al. Altered expression of SHIP, a toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infection. J Infect Dis. 2011;204(8):1181–5.

    Article  CAS  Google Scholar 

  7. Strnad P, et al. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14(1):55–66.

    Article  CAS  Google Scholar 

  8. Prin M, Bakker J, Wagener G. Hepatosplanchnic circulation in cirrhosis and sepsis. World J Gastroenterol. 2015;21(9):2582–92.

    Article  CAS  Google Scholar 

  9. Schneider KM, et al. CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: limiting steatohepatitis by maintaining intestinal homeostasis. Hepatology. 2015;62(5):1405–16.

    Article  CAS  Google Scholar 

  10. Sharawy N. Vasoplegia in septic shock: do we really fight the right enemy? J Crit Care. 2014;29(1):83–7.

    Article  CAS  Google Scholar 

  11. Piano S, Bartoletti M, Tonon M, et al. Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections. Gut. Published Online First: 31 Aug 2017. https://doi.org/10.1136/gutjnl-2017-314324

    Article  Google Scholar 

  12. Jalan R, et al. The CLIF consortium acute decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. J Hepatol. 2015;62(4):831–40.

    Article  Google Scholar 

  13. Scaglione S, et al. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol. 2015;49(8):690–6.

    Article  Google Scholar 

  14. Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest. 2003;124(3):1016–20.

    Article  Google Scholar 

  15. Gustot T, et al. Severe sepsis in cirrhosis. Hepatology. 2009;50(6):2022–33.

    Article  CAS  Google Scholar 

  16. Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.

    Article  CAS  Google Scholar 

  17. Shankar-Hari M, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):775–87.

    Article  CAS  Google Scholar 

  18. Seymour CW, et al. Assessment of clinical criteria for Sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–74.

    Article  CAS  Google Scholar 

  19. Vincent JL, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.

    Article  CAS  Google Scholar 

  20. Moreau R, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–37, 1437.e1–9.

    Article  Google Scholar 

  21. Jalan R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310–24.

    Article  Google Scholar 

  22. Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77.

    Article  Google Scholar 

  23. Merli M, et al. Albumin infusion in cirrhotic patients with infections other than spontaneous bacterial peritonitis: end of the story? J Hepatol. 2015;63(3):767–8.

    Article  CAS  Google Scholar 

  24. Thevenot T, et al. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. J Hepatol. 2015;62(4):822–30.

    Article  CAS  Google Scholar 

  25. Guevara M, et al. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J Hepatol. 2012;57(4):759–65.

    Article  CAS  Google Scholar 

  26. Sort P, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341(6):403–9.

    Article  CAS  Google Scholar 

  27. Thevenot T, Monnet E, Di Martino V. Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open. J Hepatol. 2013;58(3):638–9.

    Article  CAS  Google Scholar 

  28. Guevara M, Arroyo V, Gines P. Reply to: “effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open”. J Hepatol. 2013;58(3):640.

    Article  Google Scholar 

  29. Caraceni P, et al. Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med. 2013;24(8):721–8.

    Article  CAS  Google Scholar 

  30. Roberts JA, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14(6):498–509.

    Article  Google Scholar 

  31. Iacobone E, et al. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med. 2009;37(10 Suppl):S331–6.

    Article  Google Scholar 

  32. Ferenci P, et al. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–21.

    Article  Google Scholar 

  33. Tandon P, et al. Relevance of new definitions to incidence and prognosis of acute kidney injury in hospitalized patients with cirrhosis: a retrospective population-based cohort study. PLoS One. 2016;11(8):e0160394.

    Article  Google Scholar 

  34. Schiffer E, et al. Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients. Am J Transplant. 2006;6(6):1430–7.

    Article  CAS  Google Scholar 

  35. Kauffmann RM, et al. Provision of balanced nutrition protects against hypoglycemia in the critically ill surgical patient. JPEN J Parenter Enteral Nutr. 2011;35(6):686–94.

    Article  CAS  Google Scholar 

  36. Findlay JY, et al. Critical care of the end-stage liver disease patient awaiting liver transplantation. Liver Transpl. 2011;17(5):496–510.

    Article  Google Scholar 

  37. Koulaouzidis A, et al. Spontaneous bacterial peritonitis. Postgrad Med J. 2007;83(980):379–83.

    Article  CAS  Google Scholar 

  38. Gustot T, et al. Sepsis in alcohol-related liver disease. J Hepatol. 2017;67(5):1031–50.

    Article  CAS  Google Scholar 

  39. Fernández J, Bert F, Nicolas-Chanoine M-H. The challenges of multi-drug-resistance in hepatology. J Hepatol. 2016;65(5):1043–54.

    Article  Google Scholar 

  40. The challenge of antimicrobial resistance. The Lancet Gastroenterology & Hepatology. 1(3):173. https://www.thelancet.com/pdfs/journals/langas/PIIS2468-1253(16)30121-2.pdf

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Magdeburg, Magdeburg, Germany

    Antonios Katsounas

Authors
  1. Antonios Katsounas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonios Katsounas .

Editor information

Editors and Affiliations

  1. Anesthesiology and Perioperative Medicine, Penn State Hershey Medical Center, Hershey, PA, USA

    Dmitri Bezinover

  2. General, Visceral and Transplant Surgery, University of Duisburg-Essen, Essen, Germany

    Fuat Saner

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Katsounas, A. (2019). Sepsis and Septic Shock in Cirrhotic Patients. In: Bezinover, D., Saner, F. (eds) Critical Care for Potential Liver Transplant Candidates. Springer, Cham. https://doi.org/10.1007/978-3-319-92934-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92934-7_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92933-0

  • Online ISBN: 978-3-319-92934-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation